Asahi Kasei lands approval for new HSV treatment
Japanese pharma Asahi Kasei Therapeutics has snagged FDA approval for a herpes treatment that it acquired early this year in an almost $1 billion deal. The late Friday approval of Hovilpri ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.